|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
20 August 2018 |
|
Main ID: |
ChiCTR1800017696 |
|
Date of registration:
|
2018-08-10 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Effect of Magnesium Sulfate on Muscle Strength in Patients with Myasthenia Gravis
|
|
Scientific title:
|
Effect of Magnesium Sulfate on Muscle Strength in Patients with Myasthenia Gravis |
|
Date of first enrolment:
|
2016-07-01 |
|
Target sample size:
|
Group A:30;Group B:30; |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=24904 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
New Treatment Measure Clinical Study
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Shoujun Fei
|
|
Address:
|
1 Haiyuan Road, Futian District, Shenzhen, Guangdong, China
518053
|
|
Telephone:
|
+86 18682240150 |
|
Email:
|
feisj@hku-szh.org |
|
Affiliation:
|
The University of Hong Kong-Shenzhen Hospital |
|
|
Name:
|
Shoujun Fei
|
|
Address:
|
1 Haiyuan Road, Futian District, Shenzhen, Guangdong, China
518053
|
|
Telephone:
|
+86 18682240150 |
|
Email:
|
feisj@hku-szh.org |
|
Affiliation:
|
The University of Hong Kong-Shenzhen Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: ASA II-III, aged 18 to 60 years old, body weight 40 ~ 100kg, gender is not limited, elective thoracoscopic thymoma resection patients.
Exclusion criteria: Preoperative patients were excluded if the history of local anesthetic allergy, heart failure, hypertension, liver disease, diabetes, obesity (BMI> 30kg / m2), renal insufficiency, electrolyte imbalance, preoperative muscle weakness drug control Poor people.
Age minimum:
18
Age maximum:
60
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Myasthenia Gravis
|
|
Intervention(s)
|
|
Group A:Magnesium Sulfate;Group B:Normal saline;
|
|
Primary Outcome(s)
|
|
TOF;Rocuronium dose;
|
|
Source(s) of Monetary Support
|
|
no fund
|
|
Ethics review
|
Status: Approved
Approval date: 08/04/2016
Contact:
Zhiquan Chan
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|